Cerilliant's highly degreed, cross-functional team is known for much more than just developing analytical reference standards. Our reputation is also based on the Cerilliant team's ability to approach each new challenge as visionaries; to grasp the issues that challenge our customers and innovate advanced, breakthrough solutions that address their specific needs.

More than 25% of our catalog offering is a direct result of the company's commitment to introduce valuable new products to the marketplace. Cerilliant innovations include:

• Solution-based stable isotope-labeled Drugs-of-Abuse standards (parents and metabolites)
• Products with higher deuterium incorporation for greater sensitivity and more accurate results at lower concentrations
• High concentration stable labeled solution standards
• Solution-based Standards for Phytochemical/Natural Health Products
• Stable labeled Tricyclic antidepressants
• Stable labeled benzodiazepines and their metabolites
• Glucuronides of various opiates and benzodiazepines
• P450 metabolites labeled and unlabeled
• Stable labeled opiates and metabolites
• alpha/beta unsaturated ketones of opiates
• Cocaine metabolites and stable labeled analogues
• Degradation by-products of Trinitrogycerin
• ¹³C standards for all 17 toxic PCDD and PCDF isomers
• ¹³C PAH standards
• ¹³C polybrominated dioxin and furans
• Aldehyde/Ketone-DNPH standards
• Chemical Warfare Verification standards
• Sole manufacturer of high purity polyaromatic hydrocarbons (PAHs)

Cerilliant was also the first to obtain the following state and federal regulatory approvals facilitating order processing and shipments – an achievement that not only testifies to our quality, but also benefits our customers with more convenient ordering and faster delivery:

• DEA exemptions for stable labeled controlled substances
• Test Kit Numbers (TK#) for our exempt controlled substance preparations for shipment into Canada
• An ATFE license to manufacture explosive materials and DOT approval for shipping dilute standards as flammable liquids
• EPA exemption for the manufacture of PCBs